By David Ahn, MD In late August, the FDA approved Tandem Diabetes' long-awaited first software update for their X2 Insulin Pump that enables Dexcom G5 integration. With a FREE simple software update performed in the comfort of their own home, thousands of X2 users can now display CGM data (from the
When I first wrote about Medicare’s guidance in covering the Dexcom G5 Continuous Glucose Monitor (CGM), I was concerned about some wording that suggested that Medicare would not allow the use of a smartphone as a secondary display.
"An exciting nugget of information for Dexcom users was hidden among more eye-catching announcements during yesterday's Keynote Address at Apple's WWDC (Worldwide Developers Conference) in San Jose. Near the end of his preview of the upcoming watchOS 4 software update for Apple Watch, Kevin Lynch (V
News broke earlier today from CNBC's Christina Farr that Apple, Inc. has a small team of engineers working on creating sensors that can "non-invasively and continuously monitor blood sugar levels to better treat diabetes". The project is allegedly far enough along in development that Apple is invest
The pain of insulin injections is well-documented, and the diabetes community is always searching for better alternatives. One such promising technology is the long-awaited OneTouch Via, an insulin patch pump from Johnson & Johnson subsidiary Calibra Medical. Designed for both Type 1 and Type 2
Fall has come with a flurry of new products, FDA approvals, and announcements from the major players in diabetes technology. Don't miss out by checking out a quick recap of what matters: 1. Tandem Diabetes begins shipping the forward-thinking T:Slim X2 Thanks to an all-new bluetooth transmitter an
So you've read all the headlines about an artificial pancreas and how it's supposed to change the world for diabetes, but what does it really mean? We understand the skepticism... Remember: Medtronic previously claimed to have released an artificial pancreas system back in 2013. But this time, the